The Enterprise Value as of June 2026 (TTM) for Citius Pharmaceuticals, Inc. (CTXR) is 2.25M

According to Citius Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.25M. This represents a change of -85.09% compared to the average of 15.11M of the last 4 quarters.

Citius Pharmaceuticals, Inc. (CTXR) Historical Enterprise Value (quarterly & annually)

How has CTXR Enterprise Value performed in the past?

The mean historical Enterprise Value of Citius Pharmaceuticals, Inc. over the last ten years is 102.30M. The current 2.25M Enterprise Value has changed 120.15% with respect to the historical average. Over the past ten years (40 quarters), CTXR's Enterprise Value was at its highest in in the June 2021 quarter at 680.88M. The Enterprise Value was at its lowest in in the December 2025 quarter at 10.81M.

Citius Pharmaceuticals, Inc. (CTXR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Citius Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Citius Pharmaceuticals, Inc. (CTXR) Average Enterprise Value

How has CTXR Enterprise Value performed in the past?

The current Enterprise Value of Citius Pharmaceuticals, Inc. (CTXR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Citius Pharmaceuticals, Inc. (CTXR) Enterprise Value vs. Peers

How is CTXR’s Enterprise Value compared to its peers?

Citius Pharmaceuticals, Inc.’s Enterprise Value is greater than Athira Pharma, Inc. (1.07M), less than Leap Therapeutics, Inc. (30.18M), greater than SeaStar Medical Holding Corporation (-559927.00), less than Apollomics, Inc. (13.15M), greater than Curis, Inc. (-8118049.00), less than Aditxt, Inc. (3.97M), less than Moleculin Biotech, Inc. (3.96M), less than FibroBiologics, Inc. Common Stock (2.70M), less than Lunai Bioworks Inc. (9.18M), less than Daré Bioscience, Inc. (7.90M),

Build a custom stock screener for Citius Pharmaceuticals, Inc. (CTXR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Citius Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Citius Pharmaceuticals, Inc. (CTXR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Citius Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.